Editor’s Letter
First 2024 GaBI Journal issue highlights
It was with great pleasure that I assumed the role of Editor-in-Chief (EiC) of GaBI Journal in January of this year. Taking over the helm from Professor Philip D Walson… Read More »
Latest features in GaBI Journal, 2023, Issue 3
The articles in this issue of the GaBI Journal highlight two important issues that must be considered when reading scientific publications. The first two articles illustrate the rapidly expanding influence… Read More »
Extrapolation requires reading between the lines
The articles in this second issue of 2023 include an Original Research (Internet questionnaire) of the ‘opinions’ of Canadian ophthalmologists, a Review Article describing a statistical method to assess the ‘drift’… Read More »
Lagging acceptance of generic and biosimilar drug products; the rest of the story
The article in this issue of the GaBI Journal reminded me of The Rest of the Story radio programme originally hosted by Mr Paul Harvey that started each episode with,… Read More »
The importance of trust
It seems as if the entire world is dealing with a lack of trust, even in many things that have enriched and sustained human development, including our neighbours, teachers, the… Read More »
What to look forward to in GaBI Journal, 2022, Issue 2
The rate of successful development, regulatory approval and marketing of both new and follow-on biological treatments has continued to accelerate despite, and in some cases because of, a seemingly endless… Read More »
First 2022 GaBI Journal issue highlights
The first GaBI Journal issue of 2022 comes at a time of both hope and despair. While the COVID-19 pandemic continues to cause significant global morbidity and mortality; especially in… Read More »
Fourth and final issue of GaBI Journal’s 10th volume
This issue of the GaBI Journal contains only a limited number of articles, but these include two scientific very data-rich articles and an interesting and important expose on the use… Read More »
Latest features in GaBI Journal, 2021, Issue 3
This issue of GaBI Journal contains articles dealing with some very practical issues related to the evaluation, describing, and use of generic and biosimilar products. These issues include the uncertainty… Read More »
What to look forward to in GaBI Journal, 2021, Issue 2
The current pandemic has greatly amplified the already existing disparities in access to health care. Many countries are facing a lack of access to or funding to pay for the… Read More »